Archives
-
GPR35–KLF5 Signaling in DSS Colitis Repair
2026-09-13
A recent Cell Death and Disease study identifies GPR35 as a metabolic sensor that links the tryptophan–kynurenine–kynurenic acid axis to KLF5-dependent intestinal epithelial repair. Its findings connect metabolite sensing with PI3K–AKT–mTOR signaling, epithelial proliferation, and migration, refining how DSS colitis models can be interpreted in ulcerative colitis research.
-
ATRX-Deficient Glioma and RTK Inhibitor Sensitivity
2026-09-12
The reference study shows that ATRX-deficient high-grade glioma cells are more vulnerable than ATRX-proficient comparators to several receptor tyrosine kinase and PDGFR inhibitors. It further reports pronounced toxicity when selected RTK inhibitors are combined with temozolomide, supporting ATRX status as a potentially important variable in glioma drug studies and clinical-trial interpretation.
-
X-press Tag Peptide for RHEB Assays
2026-09-11
X-press Tag Peptide combines a polyhistidine handle, Xpress epitope, and enterokinase site in one N-terminal leader peptide for capture, detection, and controlled release. Its modular design is especially useful for recombinant RHEB workflows that test neddylation-linked regulation of mTORC1.
-
CX-5461 Workflow for Pol I Inhibition in Cancer
2026-09-11
CX-5461 is an RNA polymerase I inhibitor that turns ribosome-biogenesis research into a measurable workflow spanning rRNA transcription, DNA damage, mitotic catastrophe, senescence, and autophagy. This guide translates its reported activity in solid tumors and cervical cancer into practical assay design, combination testing, and troubleshooting decisions.
-
CGP 55845 Hydrochloride in Synaptic Assays
2026-09-10
Use CGP 55845 hydrochloride as a selective pharmacological gate to separate GABAB-dependent signaling from astrocytic GAT-3 effects in dentate gyrus experiments. This practical guide combines receptor antagonism, patch-clamp readouts, neurotransmitter release modulation, and troubleshooting for reproducible in vitro workflows.
-
Salinomycin: Mechanism and HCC Research Use
2026-09-10
Salinomycin is a polyether ionophore antibiotic studied in hepatocellular carcinoma research. Supplier-described findings connect cation transport, calcium elevation, Wnt/β-catenin suppression, proliferation arrest, and apoptosis, but the compound remains an experimental research reagent rather than an approved treatment.
-
CGP 55845 hydrochloride in GABA Circuit Analysis
2026-09-09
CGP 55845 hydrochloride is a high-affinity GABAB receptor antagonist for dissecting presynaptic control of neurotransmitter release. This article presents a causal assay framework that separates neuronal receptor signaling from astrocytic GAT-3 mechanisms in synaptic transmission research.
-
AO/PI Double Staining Kit: Practical Workflow
2026-09-09
The AO/PI Double Staining Kit provides a rapid fluorescent approach for separating viable, apoptotic, and necrotic cells in one live-cell assay. It is appropriate for routine cell viability and cell-death screening, but it should not be treated as a stand-alone mechanistic apoptosis assay or used without local optimization for automated, high-throughput workflows.
-
Grazoprevir Hydrate: From Protease to Translation
2026-09-08
A translational perspective on Grazoprevir hydrate and MK-5172 hydrate, connecting NS3/4A protease biology, genotype-aware assay design, pharmacology, and clinical strategy for HCV research.
-
EPI-001: An Assay-First AR Inhibition Guide
2026-09-08
EPI-001, an androgen receptor N-terminal domain inhibitor, offers a domain-aware way to study AR signaling beyond ligand-binding-domain blockade. This guide translates prostate cancer and TNBC evidence into practical model selection, assay design, and interpretation strategies.
-
FITC-Concanavalin A (ConA) Conjugate Guide
2026-09-07
FITC-Concanavalin A (ConA) Conjugate is a fluorescent lectin conjugate for visualizing α-D-glucose and α-D-mannose residues in cell-surface and tissue workflows. Use it for validated immunofluorescence or flow cytometry carbohydrate assays, not as a general probe for non-carbohydrate targets or as a substitute for a protein-specific antibody.
-
Fructus Rubi Diterpene Glycosides in BPH
2026-09-07
The reference study shows that diterpene glycosides from Fructus Rubi can reduce androgen-driven prostatic growth in DHT-stimulated RWPE-1 cells and testosterone propionate-induced rats. Its main contribution is a mechanistic model linking androgen receptor signaling with S100A2-associated TGF-β/Smad activity and epithelial–mesenchymal transition, while also illustrating how a botanical extract can be evaluated across cellular and animal systems.
-
Proteoform-Specific Drug Targeting in Native Membranes
2026-09-05
The Nature Chemistry study establishes a native-membrane mass spectrometry workflow for linking post-translational modifications to protein interactions and ligand binding. Its analysis of rhodopsin, G-protein proteoforms, and PDE6 reveals why drug selectivity can depend on molecular states that conventional cell assays and bottom-up proteomics may obscure.
-
Reparixin: A Causal Map for IL-8 Signaling
2026-09-04
Reparixin is a CXCR1/2 inhibitor for dissecting IL-8-driven inflammation, migration, and tumor signaling. This article presents a receptor-centered framework that connects MRSA extracellular-vesicle biology with rigorous assay design and translational interpretation.
-
EMD638683: SGK1 Inhibitor Workflow Guide
2026-09-04
Build a target-engagement workflow around EMD638683 to connect SGK1 signaling with NDRG1 phosphorylation, endothelial mechanics, actin remodeling, and cancer-cell responses. This practical guide separates literature-backed parameters from screening recommendations for cardiovascular and tumor research.